Age and height predict neuropathy risk in patients with HIV prescribed stavudine
Objective: Sensory neuropathy is a common problem in HIV-infected patients and is the dose-limiting toxicity of stavudine. Affordable methods of predicting neuropathy risk are needed to guide prescribing in countries where some use of stavudine remains an economic necessity. We therefore aimed to id...
Main Authors: | Cherry, C.L., Affandi, J.S., Imran, D., Yunihastuti, E., Smyth, K., Vanar, S., Kamarulzaman, A., Price, P. |
---|---|
Format: | Article |
Published: |
2009
|
Subjects: |
Similar Items
-
Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV
by: Cherry, C.L., et al.
Published: (2010) -
Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients
by: Chew, C.S.N., et al.
Published: (2011) -
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV observational Database
by: Zhou, J., et al.
Published: (2007) -
HIV-associated sensory neuropathy: Still a problem in the post-stavudine era?
by: Cherry, C, et al.
Published: (2012) -
A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients
by: Chew, C.S.N., et al.
Published: (2011)